|
2024
|
Invention
|
Markers for predicting therapeutic efficacy of a t cell. The invention relates to a method for as... |
|
2023
|
Invention
|
Cancer treatment by arsenic trioxide combination therapy.
The present invention relates to an in... |
|
|
Invention
|
Cancer treatment by arsenic trioxide combination therapy. The present invention relates to an inh... |
|
|
Invention
|
Cancer treatment by arsenic trioxide combination therapy |
|
|
Invention
|
Therapy assessment for hematopoietic cancer. The present invention concerns assessment of therapi... |
|
|
Invention
|
Therapy assessment for hematopoietic cancer |
|
2019
|
Invention
|
Novel biomarkers for sub-typing pancreatic ductal adenocarcinoma.
This invention relates to nove... |
|
2018
|
Invention
|
Novel methods for the generation and use of human induced neural border stem cells.
This inventi... |
|
|
Invention
|
Methods for the generation and use of human induced neural border stem cells. This invention rela... |
|
|
Invention
|
Methods for sub-typing and treating cancer. This invention relates to a novel approach for the id... |
|
|
Invention
|
Novel methods for sub-typing and treating cancer. This invention relates to a novel approach for ... |
|
2017
|
Invention
|
Methods for the identification and isolation of hematopoietic stem and progenitor cells. This inv... |
|
2013
|
Invention
|
Novel approaches for individualized therapy of pancreatic ductal adenocarcinoma.
This invention ... |
|
|
Invention
|
Novel approaches for individualized therapy of pancreatic ductal adenocarcinoma. This invention r... |
|
|
Invention
|
Novel biomarkers for sub-typing pancreatic ductal adenocarcinoma. This invention relates to novel... |
